Johnson & Johnson starts a final-stage drug trial of a new COVID-19 vaccine

The company plans to enroll up to 60,000 volunteers across three continents. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices